{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:40:07Z","timestamp":1746322807310,"version":"3.40.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Capital\u00e2\u20ac\u2122s Funds for Health Improvement and Research","award":["CFH 2022-1-2062"],"award-info":[{"award-number":["CFH 2022-1-2062"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"abstract":"<jats:p>The development of an easy-to-use noninvasive model to screen nonalcoholic fatty liver disease (NAFLD) is warranted. This study aimed to develop and validate a simple noninvasive NAFLD risk score (NARS). We used the National Health and Nutrition Examination Survey 2017 to March 2020 cycle data. The sample size of derivation and validation cohort were 4056 and 2502, separately. The NAFLD was determined by FibroScan\u00ae measured controlled attenuation parameter scores of &gt;285 dB\/m in the absence of excessive alcohol use, steatogenic medications use, and viral hepatitis. The NARS was derived from a multivariable logistic regression model and variables were selected based on Boruta analysis. The performance of NARS was internally validated and compared with previous models using receiver-operating characteristics curve and C-statistics. The NARS was established using waist circumference, triglycerides, alanine aminotransferase, and fasting glucose, and the total score ranges from 0 to 8, with an increasing risk of NAFLD. NARS demonstrated ideal discrimination in the validation cohort, with C-statistics of 0.832 (95% confidence interval, 0.801\u20130.824), and was not inferior to any existing models. The optimal cutoff point for predicting NAFLD was obtained at 4 scores with a sensitivity of 82% and specificity of 69%. We reported the derivation and internal validation of a novel and easy-to-use risk score for detecting the presence of NAFLD. NARS demonstrated ideal discrimination performance and was practical in clinical practice for selecting individuals at higher risk of NAFLD for further examination or intervention.<\/jats:p>","DOI":"10.1097\/md.0000000000040417","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T15:58:38Z","timestamp":1732031918000},"page":"e40417","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a risk score for detecting non-alcoholic fatty liver disease"],"prefix":"10.1097","volume":"103","author":[{"given":"Zhili","family":"Jiang","sequence":"first","affiliation":[{"name":"Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Qu","sequence":"additional","affiliation":[{"name":"Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Yi","sequence":"additional","affiliation":[{"name":"Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9036-8083","authenticated-orcid":false,"given":"Hai","family":"Gao","sequence":"additional","affiliation":[{"name":"Center for Coronary Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management.","volume":"49","author":"Vuppalanchi","year":"2009","journal-title":"Hepatology"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective.","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease.","volume":"64","author":"Marchesini","year":"2016","journal-title":"J Hepatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"100219","DOI":"10.1016\/j.jhepr.2020.100219","article-title":"Case-finding strategies in non-alcoholic fatty liver disease.","volume":"3","author":"Boursier","year":"2021","journal-title":"JHEP Rep"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/nu11122878","article-title":"Dietary patterns and components in nonalcoholic fatty liver disease (NAFLD): what key messages can health care providers offer?","volume":"11","author":"Riazi","year":"2019","journal-title":"Nutrients"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease.","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.","volume":"102","author":"Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s10620-006-3136-9","article-title":"Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?","volume":"51","author":"Duman","year":"2006","journal-title":"Dig Dis Sci"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.2442061177","article-title":"Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.","volume":"244","author":"Lee","year":"2007","journal-title":"Radiology"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0730-725X(96)00224-X","article-title":"Introduction of fast MR imaging in the assessment of hepatic steatosis.","volume":"15","author":"Fishbein","year":"1997","journal-title":"Magn Reson Imaging"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/jgh.12665","article-title":"Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).","volume":"29","author":"Otgonsuren","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-230X-10-98","article-title":"A simple index of lipid overaccumulation is a good marker of liver steatosis.","volume":"10","author":"Bedogni","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","article-title":"Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.","volume":"137","author":"Kotronen","year":"2009","journal-title":"Gastroenterology"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","article-title":"Ultrasound-based techniques for the diagnosis of liver steatosis.","volume":"25","author":"Ferraioli","year":"2019","journal-title":"World J Gastroenterol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.28394","article-title":"Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.","volume":"63","author":"Cassinotto","year":"2016","journal-title":"Hepatology"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","article-title":"Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease.","volume":"17","author":"Siddiqui","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease.","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cgh.2021.12.029","article-title":"Prevalence of high-risk nonalcoholic steatohepatitis (NASH) in the United States: results from NHANES 2017-2018.","volume":"21","author":"Vilar-Gomez","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions.","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.21037\/atm-20-2951","article-title":"Development of a simple nonalcoholic fatty liver disease scoring system indicative of metabolic risks and insulin resistance.","volume":"8","author":"Jeong","year":"2020","journal-title":"Ann Transl Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1743-7075-1-12","article-title":"Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review.","volume":"1","author":"Freedland","year":"2004","journal-title":"Nutr Metab (Lond)"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.24097","article-title":"Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.","volume":"53","author":"Ayonrinde","year":"2011","journal-title":"Hepatology"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity.","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.jacc.2010.11.058","article-title":"Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data.","volume":"57","author":"Coutinho","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/aje\/kwr048","article-title":"Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus.","volume":"174","author":"Sluik","year":"2011","journal-title":"Am J Epidemiol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe.","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ijo.2014.98","article-title":"A break in the obesity epidemic? Explained by biases or misinterpretation of the data?","volume":"39","author":"Visscher","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease.","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome.","volume":"92","author":"Kotronen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4239\/wjd.v1.i2.36","article-title":"Surrogate markers of insulin resistance: a review.","volume":"1","author":"Singh","year":"2010","journal-title":"World J Diabetes"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:03:10Z","timestamp":1746320590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":37,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040417","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}